These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9731205)

  • 1. Effects of RIalpha overexpression on cisplatin sensitivity in human ovarian carcinoma cells.
    Cvijic ME; Chin KV
    Biochem Biophys Res Commun; 1998 Aug; 249(3):723-7. PubMed ID: 9731205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin resistance and regulation of DNA repair in cAMP-dependent protein kinase mutants.
    Liu B; Cvijic ME; Jetzt A; Chin KV
    Cell Growth Differ; 1996 Aug; 7(8):1105-12. PubMed ID: 8853907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of P-glycoprotein expression in cyclic AMP-dependent protein kinase mutants.
    Cvijic ME; Chin KV
    Cell Growth Differ; 1997 Dec; 8(12):1243-7. PubMed ID: 9419412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin sensitivity in cAMP-dependent protein kinase mutants of Saccharomyces cerevisiae.
    Cvijic ME; Yang WL; Chin KV
    Anticancer Res; 1998; 18(5A):3187-92. PubMed ID: 9858882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compensatory stabilization of RIIbeta protein, cell cycle deregulation, and growth arrest in colon and prostate carcinoma cells by antisense-directed down-regulation of protein kinase A RIalpha protein.
    Nesterova M; Noguchi K; Park YG; Lee YN; Cho-Chung YS
    Clin Cancer Res; 2000 Sep; 6(9):3434-41. PubMed ID: 10999726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprevention with protein kinase A RIalpha antisense in DMBA-mammary carcinogenesis.
    Nesterova MV; Cho-Chung YS
    Ann N Y Acad Sci; 2005 Nov; 1058():255-64. PubMed ID: 16394142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow-cytometric detection of the RI alpha subunit of type I cAMP-dependent protein kinase in human cells.
    Pepe S; Ruggiero A; Tortora G; Ciardiello F; Garbi C; Yokozaki H; Cho-Chung YS; Clair T; Skalhegg BS; Bianco AR
    Cytometry; 1994 Jan; 15(1):73-9. PubMed ID: 8162827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis as a determinant of tumor sensitivity to topotecan in human ovarian tumors: preclinical in vitro/in vivo studies.
    Caserini C; Pratesi G; Tortoreto M; Bedogné B; Carenini N; Supino R; Perego P; Righetti SC; Zunino F
    Clin Cancer Res; 1997 Jun; 3(6):955-61. PubMed ID: 9815771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA topoisomerase II alpha expression is associated with alkylating agent resistance.
    Eder JP; Chan VT; Ng SW; Rizvi NA; Zacharoulis S; Teicher BA; Schnipper LE
    Cancer Res; 1995 Dec; 55(24):6109-16. PubMed ID: 8521401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SKY1 is involved in cisplatin-induced cell kill in Saccharomyces cerevisiae, and inactivation of its human homologue, SRPK1, induces cisplatin resistance in a human ovarian carcinoma cell line.
    Schenk PW; Boersma AW; Brandsma JA; den Dulk H; Burger H; Stoter G; Brouwer J; Nooter K
    Cancer Res; 2001 Oct; 61(19):6982-6. PubMed ID: 11585720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of interleukin-1 alpha and tumour necrosis factor-alpha on cisplatin-induced ERCC-1 mRNA expression in a human ovarian carcinoma cell line.
    Li Q; Bostick-Bruton F; Reed E
    Anticancer Res; 1998; 18(4A):2283-7. PubMed ID: 9703867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense protein kinase A RIalpha inhibits 7,12-dimethylbenz(a)anthracene-induction of mammary cancer: blockade at the initial phase of carcinogenesis.
    Nesterova MV; Cho-Chung YS
    Clin Cancer Res; 2004 Jul; 10(13):4568-77. PubMed ID: 15240549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic AMP-dependent protein kinase type I is involved in hypersensitivity of human breast cells to topoisomerase II inhibitors.
    Tortora G; Ciardiello F; Damiano V; Pepe S; Bianco C; di Isernia G; Davies SL; North P; Harris AL; Hickson ID
    Clin Cancer Res; 1995 Jan; 1(1):49-56. PubMed ID: 9815886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of the RIalpha subunit of the cAMP-dependent protein kinase A is associated with advanced stage ovarian cancer.
    McDaid HM; Cairns MT; Atkinson RJ; McAleer S; Harkin DP; Gilmore P; Johnston PG
    Br J Cancer; 1999 Feb; 79(5-6):933-9. PubMed ID: 10070893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCL-2 family protein expression and platinum drug resistance in ovarian carcinoma.
    Beale PJ; Rogers P; Boxall F; Sharp SY; Kelland LR
    Br J Cancer; 2000 Jan; 82(2):436-40. PubMed ID: 10646901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression.
    Li D; Williams JI; Pietras RJ
    Oncogene; 2002 Apr; 21(18):2805-14. PubMed ID: 11973639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of DNA methyltransferase reverses cisplatin induced drug resistance in murine neuroblastoma cells.
    Qiu YY; Mirkin BL; Dwivedi RS
    Cancer Detect Prev; 2005; 29(5):456-63. PubMed ID: 16185816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The RI alpha subunit of protein kinase A controls serum dependency and entry into cell cycle of human mammary epithelial cells.
    Tortora G; Pepe S; Bianco C; Baldassarre G; Budillon A; Clair T; Cho-Chung YS; Bianco AR; Ciardiello F
    Oncogene; 1994 Nov; 9(11):3233-40. PubMed ID: 7936647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a cAMP-dependent protein kinase mutant resistant to cisplatin.
    Cvijic ME; Chin KV
    Int J Cancer; 1997 Jul; 72(2):345-50. PubMed ID: 9219844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG immunomer DNA enhances antisense protein kinase A RIalpha inhibition of multidrug-resistant colon carcinoma growth in nude mice: molecular basis for combinatorial therapy.
    Nesterova MV; Johnson NR; Stewart T; Abrams S; Cho-Chung YS
    Clin Cancer Res; 2005 Aug; 11(16):5950-5. PubMed ID: 16115938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.